NAVIFUS CORP. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 30.4 TWD | -0.49% |
|
+1.33% | +6.29% |
| 1 week | +1.33% | ||
| Current month | +1.33% |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site
| 1 day | -0.49% | ||
| 1 week | +1.33% | ||
| Current month | +1.33% | ||
| 1 month | -2.25% | ||
| 3 months | +9.35% | ||
| 6 months | +27.73% | ||
| Current year | +6.29% |
1 week
30.00
30.75
1 month
28.5031.25
Current year
26.9031.95
1 year
22.6531.95
3 years
17.9549.45
5 years
17.9549.45
10 years
17.9549.45
| Managers | Title | Age | Since |
|---|---|---|---|
Arthur Lung
CEO | Chief Executive Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jen Chen
CHM | Chairman | - | - |
Hao-Li Liu
FOU | Founder | - | 01/15/01 |
Zhen Yu Long
BRD | Director/Board Member | - | - |
NaviFUS Corp is a Taiwan-based company mainly engaged in the development of medical devices. The Company focuses on the development of two core technology platforms: focused ultrasound systems and therapeutic guidance tracking systems. The Company focuses on the development of medical systems for recurrent brain tumors and Alzheimer's disease.
| 1st Jan change | Capi. | |
|---|---|---|
| +6.29% | 53.15M | |
| +8.88% | 219B | |
| +8.68% | 185B | |
| +14.25% | 135B | |
| +28.18% | 107B | |
| +14.65% | 51.28B | |
| +4.48% | 51.01B | |
| +4.39% | 41.85B | |
| +7.00% | 37.02B | |
| +26.06% | 31.27B |
- Stock Market
- Equities
- 6872 Stock